ClinicalTrials.gg
CompletedNCT03355144ROBSTAUpdated May 22, 2018

Resident Observed Burnout After Daily Supplementation With Coffee

An interventional study of Daily Supplementation with Coffee in Burnout, Professional, sponsored by NYU Langone Health. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2018-05-22.

Sponsored by NYU Langone Health · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
39
Allocation
Not applicable
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 96 studies in Burnout, Professional with a site in United States — 10 open to participants now, 16 under way, none of them phase 3. Burnout, Professional · United States.

Enrollment
71st of 89
39 · median 74
Started
2018
with 11 others
No phase
87 of 96
8 open now
Registered
16th of 96
by date

Among the 96 studies in Burnout, Professional with a site in United States, this one is the 71st largest by enrollment of the 89 interventional ones that give a count, is one of 12 that started in 2018, is one of 87 with no phase, and was the 16th registered.

Burnout, Professional

216 studies on the registry are indexed under Burnout, Professional; 33 are open to participants now.

Browse Burnout, Professional studies →

Open to participants now

10 of the 96 studies in Burnout, Professional with a site in United States are open now. Recruiting first, the newest first:

5 more — sign in →

All 10 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 14 Burnout, Professional studies recruiting now, 9 (64%) set no upper age limit and 5 (36%) stop at 75 or younger; 1 takes children under 18; 9 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 96 studies in Burnout, Professional with a site in United States, or all of them as a file.
02

Study summary

Coffee drinking is frequently reported as a negative outcome in studies on burnout, but the effect of an increased coffee intake on resident burnout has not been reported in the literature. This study is a prospective, interventional cohort study enrolling up to 50 residents from the Internal Medicine Residency Program to look at the relationship between coffee and resident burnout.

Read the detailed description

Resident burnout is increasingly being recognized as detrimental to both physician well being and patient care. It has been linked to an increased rate of medical errors and a reduced quality of patient care. In addition, there have been multiple high-profile physician suicides in the past years. This has resulted in a renewed focus on physician mental health and workload.

03

Conditions studied

  • Burnout, Professional

Browse trials for

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • A resident in the NYU Internal Medicine residency program

Exclusion criteria

Exclusion Criteria:

  • Allergy or intolerance to coffee or caffeine
  • Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
39 participants (actual)

Study arms

  • Experimental
    Internal Medicine residents at NYU

    effect of supplying Internal Medicine residents at NYU with free coffee on self reported features of psychological health, energy and burnout

    Dietary Supplement: Daily Supplementation with Coffee

Interventions

  • Dietary supplementDaily Supplementation with Coffee

    At the beginning of study week 2 (study day 8), two coffee machines (one Nespresso Inissia and one Hamilton Beach 46205 12 Cup Programmable Coffee Maker) will be installed in the resident work rooms at each site. Subjects will be provided with free coffee beans, milk, cream, sugar and sweetener

06

What researchers measure

Primary outcomes

  1. Self reported feelings of burnout

    14 question survey measuring number of cups of coffee and level of exhaustion

    Time frame: 1 Month

Secondary outcomes

  1. Coffee consumption measured by self reporting questionaire

    Measured by self reporting questionnaire

    Time frame: 1 Month

  2. Self reported emotional well being

    14 question survey with questions measuring emotional wellbeing

    Time frame: 1 Month

  3. Self reported feelings of value

    14 question survey with questions measuring feelings of self value

    Time frame: 1 Month

07

Study locations

1 site
  • New York University School of Medicine
    New York, New York 10016, United States
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2018 to primary completion in Apr 2018, 0 months.

Of 128 non-industry interventional studies with no phase under Burnout, Professional, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 22. This study's 0 months is below that.

Counting every sponsor, half of 132 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 22, 2017
First posted
Nov 28, 2017
StartActual
Mar 22, 2018
Primary completionActual
Apr 12, 2018
CompletionActual
Apr 12, 2018
Last update
May 22, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 22, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03355144
Lead sponsor
NYU Langone Health
Responsible party
Sponsor
First posted
Nov 28, 2017
Start date
Mar 22, 2018
Primary completion
Apr 12, 2018
Completion
Apr 12, 2018
Last update
May 22, 2018

Study contacts

Steven Liu, MD
principal investigator · NYU Langone Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion